Scancell Holdings plc (LON:SCLP - Get Free Report) insider Martin Diggle purchased 44,944 shares of the firm's stock in a transaction on Tuesday, May 20th. The stock was acquired at an average cost of GBX 9 ($0.12) per share, for a total transaction of £4,044.96 ($5,417.12).
Scancell Stock Up 8.8%
Shares of LON:SCLP opened at GBX 10.06 ($0.13) on Wednesday. The stock's 50-day moving average price is GBX 9.32 and its two-hundred day moving average price is GBX 10.24. The company has a current ratio of 3.42, a quick ratio of 13.01 and a debt-to-equity ratio of -566.79. Scancell Holdings plc has a 12-month low of GBX 7.26 ($0.10) and a 12-month high of GBX 19.75 ($0.26). The firm has a market cap of £104.19 million, a price-to-earnings ratio of -15.42 and a beta of 0.35.
About Scancell
(
Get Free Report)
Scancell LSE: SCLP is a clinical stage immunotherapy biotech company developing treatments for significant unmet needs in cancer. We aim to translate our innovation and creativity into increased and durable responses in patients without compromising safety, addressing hard-to-treat cancers.
Scancell has developed a pipeline of ‘off-the-shelf' vaccines to induce immune responses and highly tumour specific monoclonal antibodies to redirect immune cells or drugs.
See Also
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Scancell, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Scancell wasn't on the list.
While Scancell currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Which stocks are likely to thrive in today's challenging market? Enter your email address and we'll send you MarketBeat's list of ten stocks that will drive in any economic environment.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
